News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center
Logo of MD Anderson Cancer Center from X
Oct 24, 2023, 13:44

MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center

Quoting

“MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone.

“These findings showcase, for the first time, the potential of combining immunotherapy with a PARP inhibitor to deliver significant clinical improvements for these patients,” says lead investigator Shannon Westin.”

For more details click here.
cancer Endometrial cancer Headlines MD Anderson Cancer Center OncoDaily Oncology Shannon Westin
Special Coverage
Blog
Feb 11, 2025, 03:46
Historical Perspective of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Blog
Feb 10, 2025, 18:28
Narjust Florez: Thank you ASCO - never imagined this to happen when still in my 30s
Blog
Feb 10, 2025, 18:24
Stephanie Graff: Thank you, ASCO, for the beautiful award
Science
Feb 10, 2025, 18:20
Leela Morená: Xenotransplantation of a porcine kidney for end-stage kidney disease
Blog
Feb 10, 2025, 18:17
New 2025-2027 committee nominations are now open - IASLC
Blog
Feb 10, 2025, 18:10
Rasu Shrestha: Proud of what we, as a team across Advocate Health, have already accomplished
Blog
Feb 10, 2025, 17:17
Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Blog
Feb 10, 2025, 16:55
Did you know that some cancer treatments cause cardiotoxicity? - Oncogene Cancer Research
Blog
Feb 10, 2025, 16:49
AAMC Statement on Drastic Cuts to NIH-Funded Research
Science
Feb 10, 2025, 16:45
Patrick Hwu: The potential of personalized cancer vaccines as an effective adjuvant therapy in RCC
Insight
Feb 10, 2025, 16:08
Drew Moghanaki: A common-sense interpretation of clinical trial data
Blog
Feb 10, 2025, 15:56
Herbert Loong: Join us for the inaugural ESMO TAT Asia 2025 meeting